Cargando…

New Perfluorophtalate Complexes of Platinum(II) With Chemotherapeutic Potential

Two new platinum(II) complexes have been synthesized and their anti-tumour and anti-HIV activities have been evaluated. The new complexes are: (i) cis-tetrafluorophthalate-ammine-morpholine-platinum(II) or MMF3 and (ii) cis-tetrafluorophthalate- ammine-piperidine-platinum(II) or MPF4. They were char...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Oliveira, M. B., Miller, J., Banks, R. E., Kelland, L. R., McAuliffe, C. A., Mahmood, N., Rowland, I. J.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 1996
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365017/ https://www.ncbi.nlm.nih.gov/pubmed/18472806 http://dx.doi.org/10.1155/MBD.1996.117

Ejemplares similares

In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473.
por: Holford, J., et al.
Publicado: (1998)

Acquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenografts.
por: Jones, M., et al.
Publicado: (1993)

STATing the importance of immune modulation by platinum chemotherapeutics
por: Hato, Stanleyson V., et al.
Publicado: (2012)

Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents
por: Gersten, Benjamin K., et al.
Publicado: (2020)

Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes.
por: Hills, C. A., et al.
Publicado: (1989)

Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes.
por: Loh, S. Y., et al.
Publicado: (1992)

Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics
por: Ferraro, Maria Grazia, et al.
Publicado: (2022)

New platinum(II) complexes with benzothiazole ligands
por: Carmona-Negrón, José A., et al.
Publicado: (2016)

Mechanism of action of an orally administered platinum complex [ammine bis butyrato cyclohexylamine dichloroplatinum (IV) (JM221)] in intrinsically cisplatin-resistant human ovarian carcinoma in vitro.
por: McKeage, M. J., et al.
Publicado: (1994)

Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics
por: Schoch, Sarah, et al.
Publicado: (2020)

A novel platinum-based chemotherapeutic inducing immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2020)

BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma
por: Beale, P J, et al.
Publicado: (2000)

In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
por: Mellish, K. J., et al.
Publicado: (1993)

Structural Preferences in Phosphanylthiolato Platinum(II) Complexes
por: Duran, Josep, et al.
Publicado: (2015)

Structural Preferences in Phosphanylthiolato Platinum(II) Complexes
por: Duran, Josep, et al.
Publicado: (2016)

Intracellular metabolism of the orally active platinum drug JM216: influence of glutathione levels.
por: Raynaud, F. I., et al.
Publicado: (1996)

Antioxidant Supplementation in the Treatment of Neurotoxicity Induced by Platinum-Based Chemotherapeutics—A Review
por: Stankovic, Jelena S. Katanic, et al.
Publicado: (2020)

The Role of mTORC1 Pathway and Autophagy in Resistance to Platinum-Based Chemotherapeutics
por: Pan, Zhenrui, et al.
Publicado: (2023)

Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines.
por: Sharp, S. Y., et al.
Publicado: (1998)

Potential Switchable Circularly Polarized Luminescence from Chiral Cyclometalated Platinum(II) Complexes
por: Zhang, Xiao-Peng, et al.
Publicado: (2014)

Development of Acid-Sensitive Platinum(II) Complexes With Protein-Binding Properties
por: Schütte, M. T., et al.
Publicado: (2000)

Monofunctional and Interstrand DNA Adducts of Platinum(II) Complexes
por: Brabec, Viktor, et al.
Publicado: (1994)

The role of expression and polymorphism of the BAG-1 gene in response to platinum-based chemotherapeutics in NSCLC
por: WANG, YA-DI, et al.
Publicado: (2011)

Platinum and other metal coordination compounds in cancer chemotherapy. A commentary on the sixth international symposium: San Diego, California, 23-26th January 1991.
por: McKeage, M. J., et al.
Publicado: (1991)

Fertility Inhibitor Heterobimetallic Complexes of Platinum(II) and Palladium(II): Synthetic, Spectroscopic and Antimicrobial Aspects
por: Sharma, Kripa, et al.
Publicado: (2000)

The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.
por: Mistry, P., et al.
Publicado: (1991)

Identification of Platinum(II) Sulfide Complexes Suitable as Intramuscular Cyanide Countermeasures
por: Behymer, Matthew M., et al.
Publicado: (2022)

Platinum complexes inhibit repair of potentially lethal damage following bleomycin treatment.
por: Holden, S. A., et al.
Publicado: (1987)

Platinum(II)-Acyclovir Complexes: Synthesis, Antiviral and Antitumour Activity
por: Coluccia, M., et al.
Publicado: (1995)

Bent Dinuclear Platinum(II) Halo-Bridged Carbonyl Complexes
por: Dell'Amico, Daniela Belli, et al.
Publicado: (2011)

Regulation of the Switchable Luminescence of Tridentate Platinum(II) Complexes by Photoisomerization
por: Li, Yongguang, et al.
Publicado: (2021)

Antileukemia Activity and Mechanism of Platinum(II)-Based Metal Complexes
por: Di Pietro, Maria Letizia, et al.
Publicado: (2022)

The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric study.
por: Ormerod, M. G., et al.
Publicado: (1996)

Toxicological and Tumoricidal Evaluations of a New Platinum Complex, (–)‐(R)‐2‐Aminomethy lpyrrolidine (1,1‐cyclobutanedicarboxylato) platinum (II) Monohydrate, in Rats
por: Akamatsu, Ken‐ichi, et al.
Publicado: (1991)

New Platinum(II) Complexes Affecting Different Biomolecular Targets in Resistant Ovarian Carcinoma Cells
por: Hyeraci, Mariafrancesca, et al.
Publicado: (2021)

Platinum complexes of curcumin delivered by dual-responsive polymeric nanoparticles improve chemotherapeutic efficacy based on the enhanced anti-metastasis activity and reduce side effects
por: Chen, Yan, et al.
Publicado: (2020)

Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Properties
por: Frik, Malgorzata, et al.
Publicado: (2015)

Schistosoma mansoni Sirtuins: Characterization and Potential as Chemotherapeutic Targets
por: Lancelot, Julien, et al.
Publicado: (2013)

New Palladium(II) and Platinum(II) Complexes Based on Pyrrole Schiff Bases: Synthesis, Characterization, X-ray Structure, and Anticancer Activity
por: Mbugua, Simon N., et al.
Publicado: (2020)

Guanidine platinum(II) complexes: synthesis, in vitro antitumor activity, and DNA interactions()
por: Legin, Anton A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t2h2stmbvb90v4sk4qhrrgjoud